How cross-border cooperation is redefining healthcare enforcement and asset recovery in complex fraud investigations
WASHINGTON, DC, December 3, 2025
For decades, U.S. Medicare fraud was treated primarily as a domestic crime against a domestic program. Investigations centered on clinics, billing companies, and pharmacies within the United States, and the narrative rarely extended beyond its borders. That picture has changed.
Today, major Medicare fraud schemes regularly involve offshore call centers, nominee owners in foreign jurisdictions, shell companies registered in multiple countries, and fugitives who vanish into international financial and travel networks. As a result, the fallout from these crimes now reaches far beyond the American health system, pulling in foreign prosecutors, banks, and regulators and reshaping global cooperation in healthcare enforcement and asset recovery.
This evolving landscape is forcing governments, courts, and private-sector compliance professionals to confront a complex mix of extradition law, cross-border data sharing, and the technical challenge of tracing digital money flows back to stolen public funds.
A domestic health program with international consequences
Medicare is funded by U.S. taxpayers and designed to serve American beneficiaries, yet its fraud risks are increasingly international in scope. Large telemedicine schemes, genetic testing scams, pharmacy networks, and durable medical equipment operations often route critical pieces of their activity offshore. Call centers that recruit Medicare beneficiaries may be located in Eastern Europe or South Asia. Shell holding companies might be registered in the Caribbean, the Middle East, or parts of Africa. Proceeds can flow through correspondent banking relationships into accounts in Asia or Latin America before landing in offshore investment structures.
As U.S. enforcement has intensified, these international layers have taken on new significance. When a fraud organizer, marketer, or financial facilitator leaves the United States before indictment or sentencing, the authorities must rely on extradition treaties, mutual legal assistance agreements, and cross-border investigative partnerships to bring them back. In parallel, efforts to recover stolen funds now routinely depend on cooperation from foreign regulators and banks that may have no direct stake in the Medicare program but are now custodians of tainted assets.
This is not only a question of punishing individual offenders. It is also about protecting the integrity of financial systems in emerging markets, preventing local institutions from unwittingly serving as conduits for foreign public-sector theft, and maintaining trust in the international frameworks that underpin global health and financial cooperation.
Case study 1: Operation Brace Yourself and the offshore echo
One of the clearest examples of how Medicare fraud radiates beyond U.S. borders comes from the series of orthopedic brace and telemedicine schemes that federal agents collectively described under banners such as Operation Brace Yourself.
In those cases, U.S. authorities alleged that a network of call centers, telemedicine entities, and durable medical equipment suppliers conspired to bill Medicare for medically unnecessary back, wrist, and knee braces. Seniors across the United States were targeted by unsolicited calls offering “free” braces if they provided their Medicare numbers and basic medical information. Physicians, often working under telehealth contracts that paid per consultation, were accused of signing off on large volumes of orders with minimal patient interaction.
Behind the U.S.-based shell companies and billing entities, investigators found international links. Overseas call centers supported telemarketing operations. Some of the corporate structures used to receive payments and distribute proceeds were organized in foreign jurisdictions. When the Department of Justice and the Department of Health and Human Services Office of Inspector General initiated coordinated takedowns, they discovered that not all participants chose to remain within reach of U.S. marshals.
One of the most striking elements of these brace schemes was the fate of specific high-level organizers. After pleading guilty to charges including conspiracy to commit healthcare fraud and violations of anti-kickback laws, one central figure failed to appear for sentencing and is now listed as a most-wanted healthcare fraud fugitive. Public records describe him as believed to be living abroad, with investigators indicating he may have fled to the Philippines.
The legal story did not end with his disappearance. Courts still moved ahead with restitution orders and forfeiture actions. Co-defendants, including other executives and medical professionals, were sentenced, and the U.S. government continued to pursue the tracing and recovery of assets linked to the broader scheme. Yet the flight of a key organizer underscored a central tension in modern enforcement: when criminals exploit cross-border networks, how effectively can justice systems follow them?
Extradition in the era of digital healthcare fraud
Extradition is the formal process by which one country surrenders an individual to another country for prosecution or punishment. In theory, clear treaties and shared commitments to combating corruption and fraud should make this process straightforward. In practice, Medicare fraud cases highlight several complications.
First, many nations treat financial crime as a lower priority than violent crime or national security offenses. While U.S. authorities may view significant healthcare frauds as serious threats to public resources, some foreign jurisdictions, especially those with limited investigative capacity, may view such cases as distant, technical disputes over billing codes and insurance rules. Convincing foreign courts that a Medicare fraud fugitive deserves priority attention often requires sustained diplomatic engagement and detailed legal argument.
Second, extradition is governed by the principle of dual criminality. The conduct in question generally must be a crime in both the requesting and requested states. While nearly all jurisdictions criminalize fraud in broad terms, the specific structure of U.S. healthcare laws, including the False Claims Act and specialized anti-kickback statutes, does not always map neatly onto foreign legal systems. Defense attorneys can and do argue that their clients’ conduct, mainly when described in terms of telemarketing or aggressive business practices, does not fit neatly within local criminal definitions.
Third, political and humanitarian considerations play a role. Extradition may be opposed on grounds of the requested person’s health, family ties, or fears of disproportionate punishment. In some instances, foreign courts are wary of sending their residents or citizens to face long potential sentences in the United States for crimes that did not directly affect their home country’s taxpayers.
Despite these challenges, there are growing signs of more assertive cross-border cooperation. U.S. agencies have expanded liaison relationships with foreign law enforcement, and joint investigative teams have become more common in complex financial crime cases. Countries that might previously have hesitated to act on Medicare fraud requests now increasingly see such cooperation as part of a broader global effort to combat corruption, money laundering, and the abuse of financial systems.
Restitution orders and the global hunt for assets
Even when defendants remain within U.S. jurisdiction, global issues quickly emerge once courts begin ordering restitution and forfeiture. A typical large Medicare fraud case can result in restitution orders totaling tens or hundreds of millions of dollars, reflecting the direct financial harm to public health programs. Federal authorities then face the task of converting those paper orders into recovered cash.
Many fraud organizers do not keep their profits in easily accessible domestic accounts. Proceeds are often moved through layers of shell companies, offshore trusts, nominee-controlled accounts, and real estate structures across multiple jurisdictions. Some funds may be converted into hard assets such as luxury property, yachts, or artwork. Others may flow into high-risk investment schemes or digital assets.
To locate and recover these funds, U.S. prosecutors and asset recovery specialists rely heavily on:
Mutual legal assistance treaties allow countries to request investigative and enforcement help from one another in criminal matters.
Informal networks between financial intelligence units, which can share suspicious transaction reports and other intelligence under international standards.
Civil forfeiture proceedings that allow authorities to seize assets linked to criminal conduct, sometimes even when the individual owner is outside the jurisdiction.
Cooperation from banks and compliance teams in foreign financial institutions that may hold accounts or instruments linked to Medicare fraud proceeds.
Each of these tools depends on a baseline of trust, transparency, and legal compatibility between the United States and partner jurisdictions. Countries that lack robust anti-money-laundering frameworks or that tolerate opaque corporate structures become attractive destinations for healthcare fraud proceeds and difficult venues for restitution efforts.
Case study 2: Telehealth fraud proceeds and the Caribbean connection
A generic pattern, reflected in multiple investigations, illustrates how complex the asset recovery landscape can be.
In one composite scenario, a group of U.S. marketers and medical professionals uses a telehealth platform to steer Medicare beneficiaries away from unnecessary lab tests and device orders. The scheme generates tens of millions of dollars in fraudulent reimbursements. The money is initially paid into domestic business accounts held by shell medical supply companies and management entities.
From there, large wire transfers are sent to an ostensibly unrelated consulting firm registered in a Caribbean jurisdiction. The local entity lists nominee directors and uses a mail-drop office. Funds then move again, this time to private investment accounts held at banks in a different region, perhaps in Europe or the Middle East, where they are mixed with other funds and invested in securities and real estate.
When U.S. authorities file criminal charges and secure indictments, they discover that the principals have limited visible assets in the United States. Yet bank records obtained through subpoenas and foreign assistance requests paint a more detailed picture, showing multi-million-dollar transfers aligned with the timeframe of the Medicare fraud.
To recover these assets, the United States must:
Persuade Caribbean authorities to recognize the U.S. judgment or cooperate in local forfeiture actions.
Convince foreign banks to freeze accounts, often on tight timelines, before the funds can be moved again.
Demonstrate to foreign courts that the money in question truly originates from criminal healthcare fraud, not just aggressive business operations or tax planning.
Emerging markets now face their own reputational stakes. Jurisdictions that respond promptly and transparently to such requests reinforce their position as compliant financial centers and reduce the risk of being labeled high-risk by global standard-setters. Those who do not cooperate may find themselves facing increased scrutiny, de-risking by international banks, and the potential loss of legitimate financial flows.
Fugitives, safe havens, and shifting norms
The presence of U.S. healthcare fraud fugitives in other countries raises uncomfortable questions about safe havens. Historically, some individuals involved in significant fraud have attempted to settle in jurisdictions with limited extradition relationships, weak enforcement, or political instability that complicates cooperation.
However, the global environment is changing. In recent years, there has been growing international pressure, driven by organizations such as the Financial Action Task Force and regional bodies, to target serious financial crime and its facilitators. While Medicare fraud is often framed as a domestic U.S. issue, the techniques used to launder proceeds resemble those used in corruption, drug trafficking, and other high-priority offenses.
As a result, countries that might once have ignored or downplayed U.S. extradition requests for healthcare fraud now face greater external and internal pressure to act. Foreign taxpayers and regulators do not want their jurisdictions to become known as retirement destinations for perpetrators of large-scale public-sector theft. Banks do not want to lose correspondent relationships because of repeated association with U.S. criminal cases.
At the same time, the legal standards for pursuing fugitives are evolving. Some countries have begun to cooperate more readily in deportation or removal proceedings for foreign nationals linked to significant financial crime, even when formal extradition is slow or contested. Others have strengthened their domestic laws to prosecute money laundering and related offenses occurring on their territory, creating alternative pathways to accountability.
Case study 3: From Medicare fraud to international fugitive status
A composite example, drawing on elements from several public cases, helps illustrate how these dynamics intersect.
A senior executive at a U.S.-based telemarketing and healthcare services company plays a central role in organizing a large Medicare fraud scheme. Under his direction, call centers solicit seniors for braces and lab tests, physicians are paid to approve orders with minimal review, and shell entities are used to submit claims and receive reimbursements.
After a federal investigation, he is charged with conspiracy to commit healthcare fraud and violating anti-kickback laws. Facing the prospect of a lengthy sentence and substantial restitution orders, he pleads guilty as part of a cooperation agreement, providing information about other participants and foreign call center arrangements.
Before sentencing, however, he disappears. Travel records and informant reports suggest he has left the United States and may be living in Southeast Asia. The Department of Health and Human Services Office of Inspector General adds him to its public list of most wanted healthcare fraud fugitives.
From that point forward, enforcement moves on two tracks. Domestically, courts finalize restitution and forfeiture orders. Co-defendants are sentenced. Investigators continue to trace funds, focusing on bank accounts, real estate, and business interests that might be tied to the fraud. Internationally, law enforcement agencies work with foreign counterparts to locate and, if possible, detain the fugitive.
Local authorities in the country where he is believed to be residing must weigh several questions:
Does his conduct clearly violate local law as well as U.S. law?
Is there a binding extradition treaty, and if so, do the conditions apply?
What evidence can the United States provide to demonstrate that the underlying conduct is severe and proven enough to justify extradition?
How will local political, diplomatic, or human rights considerations influence the outcome?
Meanwhile, the fugitive’s assets are not static. He may seek to move funds under new identities, through new business ventures, or into digital assets that are harder to trace. Each of these moves creates new data points that investigators can potentially exploit, but also extends the timeline and the complexity of global asset recovery.
The role of private sector compliance and investigative consultancies
Government agencies are central to pursuing extradition and restitution, but they are not the only actors shaping outcomes. Banks, insurers, and multinational healthcare companies are increasingly central to detecting and preventing Medicare-related fraud with international dimensions.
Financial institutions, particularly in emerging markets, face heightened expectations. Under global anti-money-laundering standards, banks are expected to understand the source of funds, monitor for unusual patterns, and report suspicious activity. Large international transfers originating from U.S. healthcare entities, especially when routed through shell companies, now attract closer scrutiny.
On the healthcare side, telemedicine platforms, device manufacturers, and lab networks with cross-border operations must navigate not only U.S. regulations but also foreign data protection laws, anti-corruption statutes, and local licensing requirements.
In this environment, specialized advisory firms have emerged to help clients understand and mitigate these risks. Amicus International Consulting is one example of a consultancy that focuses on the intersection of cross-border legal compliance, financial structuring, and regulatory exposure. Its professional services include working with healthcare providers, digital health platforms, insurers, and financial institutions to:
Map their exposure to U.S. healthcare enforcement in a global context.
Assess whether foreign subsidiaries, affiliates, or counterparties could become entangled in U.S. fraud investigations.
Review corporate structures and beneficial ownership arrangements for vulnerabilities that could be exploited by fraudulent actors or misunderstood by regulators.
Support asset-tracing efforts and internal investigations when potential links to Medicare fraud or other public-sector offenses are identified.
Such firms do not replace law enforcement, but they play a significant preventive role. By helping clients design transparent, compliant structures and control frameworks, they reduce the risk that legitimate businesses in emerging markets will be drawn into the slipstream of U.S. healthcare fraud investigations.
Cross-border data, privacy, and cooperation
Healthcare fraud investigations increasingly depend on data: billing records, telehealth logs, call center recordings, cross-border wire transfers, and internal communications. When these data sets cross borders, investigators must navigate not only criminal procedure law but also privacy and data protection regimes such as the European Union’s General Data Protection Regulation and similar frameworks elsewhere.
On one hand, robust data protection laws can complicate cross-border sharing of health or financial information. Authorities may face restrictions on what they can send abroad or requirements to anonymize certain elements. Private sector companies may hesitate to cooperate without apparent legal authority, fearing penalties for data misuse.
On the other hand, strong privacy regimes can enhance trust. Countries that demonstrate that they handle data carefully and lawfully are more likely to be seen as reliable partners in sensitive healthcare investigations. Carefully structured information-sharing arrangements, transparent legal gateways, and independent oversight can provide a foundation for sustained cooperation.
For Medicare-related cases, this means that investigators must build tailored strategies:
Narrowly defining the data they seek, focusing on what is necessary to prove fraud and trace assets.
Working closely with foreign data protection authorities to ensure that information requests comply with local law.
Balancing the need for effective enforcement with respect for patient confidentiality and the rights of individuals whose data may have been misused by fraudsters.
Policy implications for emerging markets
The global fallout of U.S. Medicare fraud is not limited to law enforcement. It also affects how emerging markets position themselves in the international financial system and the broader economy.
Countries that want to attract legitimate investment, develop medical tourism or telehealth hubs, or host back-office operations for global healthcare companies must demonstrate that they are not hospitable environments for healthcare fraud proceeds. That means:
Strengthening anti-money-laundering and counter-terrorist-financing frameworks, including enforcement capacity.
Reforming company registries to improve transparency around beneficial ownership.
Training regulators, financial institutions, and healthcare authorities to recognize patterns associated with U.S. public program fraud.
Participating in international networks that share typologies, best practices, and operational intelligence on healthcare and insurance fraud.
At the same time, these countries can leverage their compliance investments as a competitive advantage. Jurisdictions that are seen as clean, predictable, and cooperative may find it easier to attract responsible capital and long-term partnerships with global healthcare and financial firms.
Practical lessons for institutions and individuals
While extradition and restitution decisions ultimately rest with governments and courts, institutions and individuals can learn several practical lessons from recent Medicare fraud cases with global dimensions.
Healthcare organizations with cross-border reach should:
Conduct rigorous due diligence on telehealth partners, call centers, and marketing affiliates, especially if they operate offshore.
Ensure that physicians and other clinicians retain genuine independence in clinical decision-making, with clear documentation and appropriate compensation structures.
Implement strong internal controls around billing, coding, and claims submission, including analytics to detect unusual patterns.
Establish clear protocols for responding to law enforcement inquiries and preserving data relevant to investigations.
Financial institutions should:
Identify clients and transaction patterns that may indicate exposure to U.S. public healthcare program funds.
Treat sudden inflows from small or newly formed U.S. medical entities as higher risk, especially when quickly sent abroad or into opaque structures.
Invest in training and technology to detect complex money flows typical of large-scale fraud cases.
Engage proactively with regulators and international partners when healthcare-related suspicious activity reports emerge.
For patients, the guidance remains more basic but still critical. Medicare beneficiaries should be cautious about unsolicited calls, read their explanation of benefits statements, and report suspicious charges or offers of “free” medical equipment or tests. Their individual vigilance remains a frontline defense against schemes that can ultimately generate global consequences.
Looking ahead: a more interconnected enforcement landscape
The story of U.S. Medicare fraud is no longer confined to American courtrooms and hospitals. It now encompasses foreign banks, offshore company registries, international law enforcement networks, and emerging markets that are striving to align with global standards.
Extradition battles, complex restitution orders, and cross-border asset recovery efforts illustrate how public healthcare fraud can reverberate through the international system. At the same time, those struggles are catalyzing significant changes: stronger compliance frameworks, greater transparency in corporate ownership, and more sophisticated cooperation between countries that once operated in isolation.
In that sense, the global fallout from Medicare fraud is driving an uncomfortable but necessary evolution. By revealing the weaknesses that criminals exploit, these cases are forcing governments and institutions to modernize their laws, practices, and partnerships. The challenge, for policymakers and practitioners alike, is to ensure that the next generation of healthcare and financial systems is resilient enough to support innovation and cross-border collaboration without becoming a playground for those who would steal from the public in one country and hide in another.
Contact Information
Phone: +1 (604) 200-5402
Signal: 604-353-4942
Telegram: 604-353-4942
Email: [email protected]
Website: www.amicusint.ca
